GFAP Reagent Kit 100 Tests
ARCHITECT - 04W1627
Device Description
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of multiple biochemical markers associated with traumatic brain injury in a clinical specimen, using a chemiluminescent immunoassay method. This test is used to detect glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) as an aid to determine the need for a neuroimaging radiological scan following head injury.
Environmental Conditions
- 30.00
- N/A
- 8.00
- 2.00
Device Sizes
No Data Available
Device Sterilization
Device Sterile: False
Sterilization Prior To Use: False
Sterilization Methods: No Data Available
Product Codes
Code: QAT
Device Name: Brain Trauma Assessment Test
Device Class: 2
Physical State: Assay kit containing antibodies, reagents and plate/or beads. General microplate reader or automated instrument with software
Definition: Intended for in vitro diagnostic use as an aid in the evaluation of patients with suspected mild traumatic brain injury (TBI) in conjunction with other clinical information to assist in determining the need for radiologic (e.g., CT, MR) head imaging per current standard of care
Submission Type ID: 1
Review Panel: IM
Review Code: N/A
Technical Method: N
Gmp Exempt Flag: Enzyme-linked immunosorbent assay
Life Sustain Support Flag: N
Unclassified Reason: N/A
Implant Flag: N
Target Area: Blood
Regulation Number: 866.5830
Third Party Flag: Y
Medical Specialty: IM
Device IdentifiersDevice Id: 00380740213954
Device Type: Primary
DeviceId Issuing Agency: GS1
Contains DI Number: N/A
Package Quantity: N/A
Package Discontinue Date: N/A
Package Status: N/A
Package Type: N/A